NASMED EGEPOLNASMED EGEPOLNASMED EGEPOL

NASMED EGEPOL

No trades
See on Supercharts
Market capitalization
‪2.59 B‬TRY
0.90TRY
‪91.78 M‬TRY
‪616.98 M‬TRY
‪25.00 M‬
Beta (1Y)
0.92
Employees (FY)
802
Change (1Y)
−49 −5.76%
Revenue / Employee (1Y)
‪25.86 K‬TRY
Net income / Employee (1Y)
‪3.85 K‬TRY

About NASMED EGEPOL


Headquarters
Izmir
Founded
2003
ISIN
TRENSMD00029
FIGI
BBG012BTVTS0
Nasmed Özel Saglik Hizmetleri Tic AS engages in the management of private healthcare centers. It operates hospitals under the brand Egepol. The company was founded by Necip Nasir, Aslan Nasir, Servet Nasir, and Nuri Nasir on March 31, 2003, and is headquartered in Izmir, Turkey.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EGEPO is 20.72 TRY — it has increased by 1.77% in the past 24 hours. Watch NASMED EGEPOL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange NASMED EGEPOL stocks are traded under the ticker EGEPO.
EGEPO stock has risen by 7.25% compared to the previous week, the month change is a 12.67% rise, over the last year NASMED EGEPOL has showed a −15.70% decrease.
EGEPO reached its all-time high on Aug 3, 2023 with the price of 32.80 TRY, and its all-time low was 4.92 TRY and was reached on Nov 3, 2021. View more price dynamics on EGEPO chart.
See other stocks reaching their highest and lowest prices.
EGEPO stock is 3.08% volatile and has beta coefficient of 0.92. Track NASMED EGEPOL stock price on the chart and check out the list of the most volatile stocks — is NASMED EGEPOL there?
Yes, you can track NASMED EGEPOL financials in yearly and quarterly reports right on TradingView.
EGEPO net income for the last quarter is ‪69.85 M‬ TRY, while the quarter before that showed ‪−678.07 K‬ TRY of net income which accounts for ‪10.40 K‬% change. Track more NASMED EGEPOL financial stats to get the full picture.
No, EGEPO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 802.00 employees. See our rating of the largest employees — is NASMED EGEPOL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NASMED EGEPOL EBITDA is ‪155.66 M‬ TRY, and current EBITDA margin is 16.61%. See more stats in NASMED EGEPOL financial statements.
Like other stocks, EGEPO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NASMED EGEPOL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NASMED EGEPOL technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NASMED EGEPOL stock shows the buy signal. See more of NASMED EGEPOL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.